Multi-criteria decision analysis for health technology assessment in Canada: Insights from an expert panel discussion

Vakaramoko Diaby, Ron Goeree, Jeffrey S Hoch, Uwe Siebert

Research output: Contribution to journalReview article

12 Scopus citations

Abstract

Multi-criteria decision analysis (MCDA), a decision-making tool, has received increasing attention in recent years, notably in the healthcare field. For Canada, it is unclear whether and how MCDA should be incorporated into the existing health technology assessment (HTA) decision-making process. To facilitate debate on improving HTA decision-making in Canada, a workshop was held in conjunction with the 8th World Congress on Health Economics of the International Health Economics Association in Toronto, Canada in July 2011. The objective of the workshop was to discuss the potential benefits and challenges related to the use of MCDA for HTA decision-making in Canada. This paper summarizes and discusses the recommendations of an expert panel convened at the workshop to discuss opportunities and concerns with reference to the implementation of MCDA in Canada.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalExpert Review of Pharmacoeconomics and Outcomes Research
Volume15
Issue number1
DOIs
StatePublished - Feb 1 2015
Externally publishedYes

Keywords

  • Canada
  • decision-making
  • health technology assessment
  • healthcare
  • multi-criteria decision analysis
  • workshop

ASJC Scopus subject areas

  • Health Policy
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Multi-criteria decision analysis for health technology assessment in Canada: Insights from an expert panel discussion'. Together they form a unique fingerprint.

  • Cite this